These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22586481)

  • 21. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.
    Zhang H; Chua KS; Guimond M; Kapoor V; Brown MV; Fleisher TA; Long LM; Bernstein D; Hill BJ; Douek DC; Berzofsky JA; Carter CS; Read EJ; Helman LJ; Mackall CL
    Nat Med; 2005 Nov; 11(11):1238-43. PubMed ID: 16227988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P21-activated kinase 2 is essential in maintenance of peripheral Foxp3
    Choi J; Pease DR; Chen S; Zhang B; Phee H
    Immunology; 2018 Jun; 154(2):309-321. PubMed ID: 29297928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development.
    McCarthy NI; Cowan JE; Nakamura K; Bacon A; Baik S; White AJ; Parnell SM; Jenkinson EJ; Jenkinson WE; Anderson G
    J Immunol; 2015 Sep; 195(6):2675-82. PubMed ID: 26254339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced and thymus-derived Foxp3⁺ regulatory T cells share a common niche.
    Huang YJ; Haist V; Baumgärtner W; Föhse L; Prinz I; Suerbaum S; Floess S; Huehn J
    Eur J Immunol; 2014 Feb; 44(2):460-8. PubMed ID: 24170313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo expansion of CD4+CD25+FoxP3+ T regulatory cells based on synergy between IL-2 and 4-1BB signaling.
    Elpek KG; Yolcu ES; Franke DD; Lacelle C; Schabowsky RH; Shirwan H
    J Immunol; 2007 Dec; 179(11):7295-304. PubMed ID: 18025172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 2 modulates thymic-derived regulatory T cell epigenetic landscape.
    Chorro L; Suzuki M; Chin SS; Williams TM; Snapp EL; Odagiu L; Labrecque N; Lauvau G
    Nat Commun; 2018 Dec; 9(1):5368. PubMed ID: 30560927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased CD127 expression on activated FOXP3+CD4+ regulatory T cells.
    Simonetta F; Chiali A; Cordier C; Urrutia A; Girault I; Bloquet S; Tanchot C; Bourgeois C
    Eur J Immunol; 2010 Sep; 40(9):2528-38. PubMed ID: 20690182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-intrinsic role for NF-kappa B-inducing kinase in peripheral maintenance but not thymic development of Foxp3+ regulatory T cells in mice.
    Murray SE
    PLoS One; 2013; 8(9):e76216. PubMed ID: 24073289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CTLA-4 is required by CD4+CD25+ Treg to control CD4+ T-cell lymphopenia-induced proliferation.
    Sojka DK; Hughson A; Fowell DJ
    Eur J Immunol; 2009 Jun; 39(6):1544-51. PubMed ID: 19462377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.
    Yang CH; Tian L; Ling GS; Trendell-Smith NJ; Ma L; Lo CK; Stott DI; Liew FY; Huang FP
    Eur J Immunol; 2008 Jun; 38(6):1664-76. PubMed ID: 18465774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-2Rbeta links IL-2R signaling with Foxp3 expression.
    Soper DM; Kasprowicz DJ; Ziegler SF
    Eur J Immunol; 2007 Jul; 37(7):1817-26. PubMed ID: 17559173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4+CD25+Foxp3+ regulatory T cells.
    Patton DT; Garden OA; Pearce WP; Clough LE; Monk CR; Leung E; Rowan WC; Sancho S; Walker LS; Vanhaesebroeck B; Okkenhaug K
    J Immunol; 2006 Nov; 177(10):6598-602. PubMed ID: 17082571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TCR triggering modulates the responsiveness and homeostatic proliferation of CD4+ thymic emigrants to IL-7 therapy.
    Hennion-Tscheltzoff O; Leboeuf D; Gauthier SD; Dupuis M; Assouline B; Grégoire A; Thiant S; Guimond M
    Blood; 2013 Jun; 121(23):4684-93. PubMed ID: 23613523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NFAT Factors Are Dispensable for the Development but Are Critical for the Maintenance of Foxp3
    Barahona de Brito C; Patra AK
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus.
    Zhan Y; Davey GM; Graham KL; Kiu H; Dudek NL; Kay T; Lew AM
    Immunol Cell Biol; 2009; 87(6):473-80. PubMed ID: 19381159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool.
    Permanyer M; Bošnjak B; Glage S; Friedrichsen M; Floess S; Huehn J; Patzer GE; Odak I; Eckert N; Zargari R; Ospina-Quintero L; Georgiev H; Förster R
    Cell Mol Immunol; 2021 Feb; 18(2):398-414. PubMed ID: 33408345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keratinocyte growth factor induces expansion of murine peripheral CD4+Foxp3+ regulatory T cells and increases their thymic output.
    Bruinsma M; van Soest PL; Leenen PJ; Lambrecht BN; Cupedo T; Löwenberg B; Cornelissen JJ; Braakman E
    J Immunol; 2007 Dec; 179(11):7424-30. PubMed ID: 18025186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.
    Miyao T; Floess S; Setoguchi R; Luche H; Fehling HJ; Waldmann H; Huehn J; Hori S
    Immunity; 2012 Feb; 36(2):262-75. PubMed ID: 22326580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.